发明名称 |
USES OF MONOCLONAL ANTIBODY 8H9 |
摘要 |
This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof. |
申请公布号 |
EP1572077(A4) |
申请公布日期 |
2005.12.14 |
申请号 |
EP20030716369 |
申请日期 |
2003.03.06 |
申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
发明人 |
CHEUNG, NAI-KONG, V. |
分类号 |
A61K6/00;A61K39/395;A61K47/48;A61K49/00;A61P43/00;C07K16/00;C07K16/18;C07K16/30;C07K16/42;C12N15/11;C12N15/63;C12N15/85;C12Q1/68;C12Q1/70;G01N33/00;G01N33/53;(IPC1-7):C07K16/00 |
主分类号 |
A61K6/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|